当前位置: X-MOL首页SCI期刊查询及投稿分析系统 › ChemMedChem杂志
ChemMedChem
基本信息
期刊名称 ChemMedChem
CHEMMEDCHEM
期刊ISSN 1860-7179
期刊官方网站 https://onlinelibrary.wiley.com/journal/18607187
是否OA No
出版商 John Wiley and Sons Ltd
出版周期 Monthly
文章处理费 登录后查看
始发年份 2006
年文章数 202
影响因子 3.6(2023)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学3区 CHEMISTRY, MEDICINAL 药物化学3区
PHARMACOLOGY & PHARMACY 药学3区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 6.7 0.761 0.750
Pharmacology, Toxicology and Pharmaceutics
General Pharmacology, Toxicology and Pharmaceutics
9/80 89%
Chemistry
Organic Chemistry
56/211 73%
Pharmacology, Toxicology and Pharmaceutics
Pharmacology
98/313 68%
Pharmacology, Toxicology and Pharmaceutics
Drug Discovery
53/157 66%
Biochemistry, Genetics and Molecular Biology
Biochemistry
155/438 64%
补充信息
自引率 2.8%
H-index 92
SCI收录状况 Science Citation Index Expanded
官方审稿时间 登录后查看
网友分享审稿时间 数据统计中,敬请期待。
接受率 登录后查看
PubMed Central (PMC) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1860-7179%5BISSN%5D
投稿指南
期刊投稿网址 https://www.editorialmanager.com/CMDC
收稿范围
Bringing chemistry, biology, and drug discovery together fosters innovation and collaboration and accelerates science. ChemMedChem publishes high-impact articles showcasing the breadth of international research in medicinal chemistry, from small pharmacologically active molecules to new modalities including nanomedicine and biologics. Our thorough editorial practices enable us to rapidly publish authoritative research. We support the community to inspire the extended drug discovery community.
收录体裁
Full Papers and Communications
Reviews and Minireviews
Patent Reviews
Highlights and Concepts
Book and Multimedia Reviews
投稿指南 https://chemistry-europe.onlinelibrary.wiley.com/hub/journal/18607187/author-guidelines
投稿模板 https://onlinelibrary.wiley.com/page/journal/18607187/homepage/2452_authors.html
参考文献格式 https://onlinelibrary.wiley.com/page/journal/18607187/homepage/2452_authors.html
编辑信息

Chairs
Karl-Heinz Altmann (ETH Zürich)
Sangyong Jon (KAIST)
Antonello Mai (Università degli Studi di Roma "La Sapienza")
Members
(Switzerland) Yves Auberson (Novartis Institute for BioMedical Research)
(Germany) Annette Beck-Sickinger (University of Leipzig)
(USA) Ashutosh Chilkoti (Duke University)
(USA) Paul J. Coleman (Merck Research Laboratories, West Point, PA)
(USA) Arun K. Ghosh (Purdue University, West Lafayette, IN)
(Spain) Jesús Jiménez Barbero (CIC bioGUNE: Center for Cooperative Research in Biosciences, Derio)
(Germany) Gerhard Klebe (Philipps-Universität Marburg)
(Italy) Filippo Minutolo (Università di Pisa)
(Italy) Marco Mor (Università degli Studi di Parma)
(China) Renxiao Wang (Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences)
(Australia) David A. Winkler (CSIRO, Clayton)
Internationa Advisory Board
(United Kingdom) Christopher Abell (University of Cambridge)
(Italy) Maria Camilla Bergonzi (University of Florence)
(Italy) Maria Laura Bolognesi (Università di Bologna)
(Italy) Maurizio Botta (Università degli Studi di Siena)
(Italy) Massimo Bottini (University of Rome Tor Vergata)
(United Kingdom) Nathan Brown (BenevolentAI, London)
(Spain)María José Camarasa (CSIC: Instituto de Química Médica, Madrid)
(China) Aoneng Cao (Shanghai University)
(Singapore) Christina Chai (National University of Singapore)
(India) Tushar K. Chakraborty (Indian Institute of Science, Bangalore)
(USA) Ravi Chari (ImmunoGen)
(Italy) Girolamo Cirrincione (Università degli Studi di Palermo)
(Germany) Bernd Clement (Christian-Albrechts-Universität Kiel)
(Sweden) Werngard Czechtizky (AstraZeneca)
(Spain) Angel R. de Lera (Universidad de Vigo)
(Italy) Carlo De Micheli (Università degli Studi di Milano)
(Switzerland) François Diederich (ETH Zürich)
(Switzerland) Beat Ernst (Universität Basel)
(USA) Omid Farokhzad (Brigham and Women's Hospital, Harvard Medical School)
(USA) Sylvie Garneau-Tsodikova (University of Kentucky)
(United Kingdom) Ian H. Gilbert (University of Dundee)
(France) Sylviane Giorgi-Renault (Université Paris Descartes)
(Spain) Ernest Giralt (Institute for Research in Biomedicine, Barcelona)
(Spain) Concepcion Gonzalez-Bello (Universidade de Santiago de Compostela)
(Austria) Ronald Gust (Universität Innsbruck)
(United Kingdom) Michael M. Hann (GlaxoSmithKline, Stevenage)
(Germany) Rolf W. Hartmann (Helmholtz Institute for Pharmaceutical Research Saarland)
(Germany) Ingo Hartung (Merck KGaA, Darmstadt)
(Czech Republic) Zlatko Janeba (Institute of Organic Chemistry and Biochemistry CAS)
(Australia) Michael Kassiou (The University of Sydney)
(Singapore) Thomas H. Keller (Experimental Therapeutics Centre, A*Star)
(South Korea) Gyochang Keum (Korea Institute of Science and Technology)
(USA) Karen Lackey (Medical University of South Carolina)
(Germany) Twan Lammers (RWTH Aachen University)
(USA) Craig W. Lindsley (Vanderbilt University, Nashville, TN)
(China) Zhuang Liu (Soochow University)
(China) Ya-Qiu Long (Soochow University)
(Germany) Rainer Metternich (Berlin)
(Italy) Stefano Moro (Università degli Studi di Padova)
(USA) Heinz E. Moser (Novartis )
(Switzerland) Klaus Mueller (ETH Zürich)
(France) Sylviane Muller (Institut de Biologie Moléculaire et Cellulaire, Strasbourg)
(Germany) Christa E. Müller (Universität Bonn)
(Germany) Peter Nussbaumer (Lead Discovery Center GmbH, Dortmund)
(United Kingdom) Paul O'Neill (University of Liverpool)
(Germany) Alleyn Plowright (Sanofi)
(Finland) Antti Poso (Itä-Suomen Yliopisto, Kuopio)
(UK) Barry V. L. Potter (University of Bath)
(Portugal) Maria M. M. Santos (University of Lisbon)
(Italy) Gianluca Sbardella (University of Salerno)
(United Kingdom) Sarah Skerratt (Vertex Pharmaceuticals)
(USA) Michael J. Sofia (Arbutus Biopharma)
(Switzerland) Martin Stahl (F. Hoffmann-La Roche Ltd)
(USA) Matthew Stanton (Generation Bio)
(Switzerland) Hans Ulrich Stilz (Novo Nordisk)
(Germany) Henning Steinhagen (Grünenthal GmbH, Aachen)
(France) Eva Toth (CNRS Orléans)
(Israel) Edit Tshuva (Hebrew University of Jerusalem)
(Belgium) Serge Van Calenbergh (Universiteit Gent)
(Germany) Klaus T. Wanner (Ludwig-Maximilians Universität München)
(Japan) Yasuyoshi Watanabe (RIKEN Center for Life Science Technologies (CLST))
(United Kingdom) Paul G. Wyatt (University of Dundee)

我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug